Viridian Therapeutics, Inc.\DE (VRDN) Institutional Ownership

Ownership Summary

Viridian Therapeutics, Inc.\DE (NASDAQ:VRDN) currently has 40 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• Institutional ownership in Viridian Therapeutics, Inc.\DE edged down to 8.8% in December 2025, compared to 91.6% in September 2025.
• The company experienced a 34.23% quarterly change in institutional shares held, alongside a decrease of 77.53% in total owners annually.
• The latest 13F cycle for Viridian Therapeutics, Inc.\DE reveals that of 40 total investors, 25 funds grew their exposure, whereas 12 reduced theirs and 3 made no changes.
• Collectively, institutional investors increased their stake in Viridian Therapeutics, Inc.\DE to 8.99Mn shares as of December 2025, a change that is up by 2.29Mn shares quarter on quarter and down 82.67Mn shares year over year.
• As of December 31, 2025, VANGUARD GROUP INC held Viridian Therapeutics, Inc.\DE's largest shareholding position with over 5.61Mn shares, representing 5.51% of total outstanding shares.
• Among the most significant buyers of Viridian Therapeutics, Inc.\DE during December 2025 were VANGUARD GROUP INC (1.28Mn), JENNISON ASSOCIATES LLC (1.15Mn), Privium Fund Management B.V. (173.52K), Universal- Beteiligungs- und Servicegesellschaft mbH (38.85K), J. Safra Sarasin Holding AG (36.57K).
• Leading sellers of Viridian Therapeutics, Inc.\DE stock in December 2025 included UBS Group AG (282.86K), Pictet Asset Management Holding SA (126.62K), PRINCIPAL FINANCIAL GROUP INC (37.40K), SG Americas Securities, LLC (29.03K), Kopp Family Office, LLC (20.66K).
• The top 10 institutional holders of Viridian Therapeutics, Inc.\DE for the quarter ending December 2025 included VANGUARD GROUP INC (5.61Mn), JENNISON ASSOCIATES LLC (1.15Mn), Pictet Asset Management Holding SA (922.77K), PRINCIPAL FINANCIAL GROUP INC (175.93K), Privium Fund Management B.V. (173.52K), Kopp Family Office, LLC (173.17K), Hennion & Walsh Asset Management, Inc. (169.17K), UBS Group AG (164.82K), MOODY ALDRICH PARTNERS LLC (96.19K), J. Safra Sarasin Holding AG (88.27K).